SEC Form 4 · accession 0001144204-17-015930
Neurotrope, Inc. · NTRP
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
William S. Singer
Director
Period of report
Mar 17, 2017
Accepted (ET)
Mar 21, 2017 · 9:51 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001513856
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F1 | $19.10 | Mar 17, 2017 | A | 10,000 | A | Mar 17, 2018 | Mar 17, 2027 | Common Stock | 10,000 | 10,000 | D |
Explanation of responses
- F1Represents the annual option grant to each of the Issuer's non-employee directors on the fifth business day after the Issuer's filing of its Annual Report on Form 10-K pursuant to the Issuer's Nonemployee Director Compensation Policy. Such option grant is subject to stockholder approval of the Issuer's 2017 Equity Incentive Plan under which the option was granted.